Back to WA Wolverine Asset Management LLC

ASASCENDIS PHARMA A/S

Showing 8 of 13 quarters

Position history for WAWolverine Asset Management LLC's holdings in ASCENDIS PHARMA A/S

As of its Q1 2026 13F, Wolverine Asset Management held 79,235,000 shares of ASCENDIS PHARMA, worth $116.3M. Wolverine Asset Management's 13F filings listed ASCENDIS PHARMA from Q2 2023 to Q1 2026, 12 quarterly filings. ASCENDIS PHARMA was 1.1% of Wolverine Asset Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$99.5M

Total Shares Change

-85.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q1
Unchanged
79.2M
0.0%
$116.3M1.1%—
0
2025-Q4
Decreased
79.2M
-15.0%
$112.4M0.9%—
0
2025-Q3
Increased
93.2M
+1.7%
$127.2M0.9%—
43
2025-Q2
Increased
91.7M
+11.6%
$114.9M1.1%—
53
2025-Q1
Increased
82.2M
+8.5%
$97.6M1.2%—
51
2024-Q4
Decreased
75.7M
-11.3%
$83.4M0.8%—
0
2024-Q3
Decreased
85.3M
-26.8%
$99.5M1.1%—
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used